WHICH DO NSCLC PATIENTS WITH EGFR MUTATION PREFER AS A FIRST-LINE THERAPY, EGFR-TKI OR CHEMOTHERAPY? A VIGNETTES STUDY (LOGIK0903)
RESPIROLOGY(2013)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined